Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

NARecruitingINTERVENTIONAL
Enrollment

14,600

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

February 2, 2027

Study Completion Date

February 2, 2027

Conditions
Cervical Cancer
Interventions
BEHAVIORAL

HPV testing of women for cervical cancer screening

Women enrolled in this study will receive HPV testing for cervical cancer screening. They will be offered self-sampling. And also they will be offered voluntary Family Planning services, as appropriate.

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
collaborator

Population Services International

OTHER

collaborator

Eduardo Mondlane University

OTHER

collaborator

William Marsh Rice University

OTHER

lead

M.D. Anderson Cancer Center

OTHER

NCT05359016 - Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique | Biotech Hunter | Biotech Hunter